Stockreport

Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)

Radiopharm Theranostics Limited - American Depositary Shares  (RADX) 
PDF First radiotherapeutic agent developed by Radiopharm Ventures, the joint venture between Radiopharm Theranostics and MD Anderson Cancer Center  Preclinical animal studi [Read more]